Back to Journals » Clinical Ophthalmology » Volume 15 » Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Please verify you are not a robot.
Back to Journals » Clinical Ophthalmology » Volume 15 » Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Please verify you are not a robot.